Karuna Therapeutics, Inc. reported Unaudited Consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company's loss from operations was $29,963,000 compared to $10,055,000 a year ago. Net loss attributable to common stockholders was $30,497,000 compared to $8,658,000 a year ago. Net loss per share, basic and diluted was $1.10 compared to $0.33 a year ago.